3B Blackbio Diagnostics Ltd. (3BBLACKBIO)
BSE
1,262.20
-4.25 (-0.34%)
Closed
Aug 25, 2026
Day's Range
1,230.001,275.15
52 wk Range
1,083.501,750.00
Financial Statements - 3BBLACKBIO - 3B Blackbio Diagnostics Ltd.
Revenue
1.41B▲ 47.1%
Net Income
599.29M▲ 25.7%Net Margin 42.2%
EBITDA
823.32M▲ 26.3%
Free Cash Flow
269.66M▼ 36.5%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 1.41B | 964.68M | 741.24M | 618.36M | 806.46M | 2.26B |
| Cost of Goods | 358.55M | 256.45M | 218.46M | 179.22M | 316.22M | 515.70M |
| Gross Profit | 1.06B | 708.22M | 522.78M | 439.14M | 490.23M | 1.75B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 516.48M | 490.23M | 322.39M | 286.29M | 364.26M | 1.49B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 769.69M | 639.98M | 443.32M | 353.09M | 432.23M | 1.52B |
| Income Tax | 170.39M | 163.07M | 122.31M | 93.72M | 110.23M | 381.66M |
| Net Income | 599.29M | 476.91M | 321.01M | 259.37M | 321.99M | 1.13B |
| EPS Basic | 69.94 | 55.66 | 37.46 | 30.27 | 43.4 | 151.661603 |
| EPS Diluted | 69.94 | 55.66 | 37.46 | 30.27 | 43.4 | 151.661603 |
| Basic Shares Outstanding | 8.37M | 8.56M | 8.56M | 8.56M | 7.49M | 7.50M |
| Diluted Shares Outstanding | 8.37M | 8.56M | 8.56M | 8.56M | 7.49M | 7.50M |
| Ebit | 772.06M | 641.06M | 444.56M | 355.07M | 433.29M | 1.52B |
| Ebitda | 823.32M | 651.92M | 396.45M | 335.87M | 440.01M | 1.52B |
| Net Income Continuous Operations | 769.69M | 639.98M | 443.32M | 353.09M | 432.23M | 1.52B |
| Minority Interests | -13.43M | -395K | 6.33M | 1.35M | -39.96M | -140.80M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
